메뉴 건너뛰기




Volumn 7, Issue 10, 2012, Pages

Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): The Influence of Gender and Genetics (CYP2D6, COMT, 5-HTT)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 2D6; METHIONINE; SEROTONIN; SEROTONIN TRANSPORTER; VALINE;

EID: 84868146648     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047599     Document Type: Article
Times cited : (46)

References (53)
  • 1
    • 84877090792 scopus 로고    scopus 로고
    • United Nations Office on Drugs and Crime Vienna
    • UNODC, United Nations New York 2010. Avalaible, Accessed 2012 Feb 14
    • UNODC, United Nations Office on Drugs and Crime Vienna. World Drug Report 2010. United Nations New York 2010. Avalaible: http://www.unodc.org/unodc/en/data-and-analysis/WDR-2010.html. Accessed 2012 Feb 14.
    • World Drug Report 2010
  • 3
    • 71949112153 scopus 로고    scopus 로고
    • 5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study
    • Martín-Santos R, Torrens M, Poudevida S, Langohr K, Cuyás E, et al. (2010) 5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study. Addict Biol 15: 15-22.
    • (2010) Addict Biol , vol.15 , pp. 15-22
    • Martín-Santos, R.1    Torrens, M.2    Poudevida, S.3    Langohr, K.4    Cuyás, E.5
  • 4
    • 63449104991 scopus 로고    scopus 로고
    • The harmful health effects of recreational ecstasy: a systematic review of observational evidence
    • Rogers G, Elston J, Garside R, Roome C, Taylor R, et al. (2009) The harmful health effects of recreational ecstasy: a systematic review of observational evidence. Health Tecnology Assessment Vol 13: No 6.
    • (2009) Health Tecnology Assessment , vol.13 , Issue.6
    • Rogers, G.1    Elston, J.2    Garside, R.3    Roome, C.4    Taylor, R.5
  • 5
    • 51849104660 scopus 로고    scopus 로고
    • Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study
    • de Sola S, Tarancón T, Peña-Casanova J, Espadaler JM, Langohr K, et al. (2008) Auditory event-related potentials (P3) and cognitive performance in recreational ecstasy polydrug users: evidence from a 12-month longitudinal study. Psychopharmacology (Berl) 200: 425-437.
    • (2008) Psychopharmacology (Berl) , vol.200 , pp. 425-437
    • de Sola, S.1    Tarancón, T.2    Peña-Casanova, J.3    Espadaler, J.M.4    Langohr, K.5
  • 7
  • 9
    • 33846937530 scopus 로고    scopus 로고
    • Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)?
    • Allott K, Redman J, (2007) Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)?. Neurosci Biobehav Rev 31: 327-347.
    • (2007) Neurosci Biobehav Rev , vol.31 , pp. 327-347
    • Allott, K.1    Redman, J.2
  • 10
    • 47249166411 scopus 로고    scopus 로고
    • Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults
    • Kolbrich EA, Goodwin RS, Gorelick DA, Hayes RJ, Stein EA, et al. (2008) Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults. Ther Drug Monit 30: 320-332.
    • (2008) Ther Drug Monit , vol.30 , pp. 320-332
    • Kolbrich, E.A.1    Goodwin, R.S.2    Gorelick, D.A.3    Hayes, R.J.4    Stein, E.A.5
  • 11
    • 81155134345 scopus 로고    scopus 로고
    • The influence of genetic and environmental factors among MDMA users in cognitive performance
    • Cuyàs E, Verdejo-García A, Fagundo AB, Khymenets O, Rodríguez J, et al. (2011) The influence of genetic and environmental factors among MDMA users in cognitive performance. PLoS One 6: e27206.
    • (2011) PLoS One , vol.6
    • Cuyàs, E.1    Verdejo-García, A.2    Fagundo, A.B.3    Khymenets, O.4    Rodríguez, J.5
  • 12
    • 24044524548 scopus 로고    scopus 로고
    • MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers
    • de la Torre R, Farré M, Mathúna BO, Roset PN, Pizarro N, et al. (2005) MDMA (ecstasy) pharmacokinetics in a CYP2D6 poor metaboliser and in nine CYP2D6 extensive metabolisers. Eur J Clin Pharmacol 61: 551-554.
    • (2005) Eur J Clin Pharmacol , vol.61 , pp. 551-554
    • de la Torre, R.1    Farré, M.2    Mathúna, B.O.3    Roset, P.N.4    Pizarro, N.5
  • 13
  • 14
    • 0006463359 scopus 로고    scopus 로고
    • Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region
    • Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, et al. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274: 1527-1531.
    • (1996) Science , vol.274 , pp. 1527-1531
    • Lesch, K.P.1    Bengel, D.2    Heils, A.3    Sabol, S.Z.4    Greenberg, B.D.5
  • 15
    • 50249104076 scopus 로고    scopus 로고
    • Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders
    • Harrison PJ, Tunbridge EM, (2008) Catechol-O-methyltransferase (COMT): a gene contributing to sex differences in brain function, and to sexual dimorphism in the predisposition to psychiatric disorders. Neuropsychopharmacology 33: 3037-3045.
    • (2008) Neuropsychopharmacology , vol.33 , pp. 3037-3045
    • Harrison, P.J.1    Tunbridge, E.M.2
  • 16
    • 70349386728 scopus 로고    scopus 로고
    • Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance Part I
    • Zhou SF, (2009) Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance Part I. Clin Pharmacokinet. 48: 689-723.
    • (2009) Clin Pharmacokinet , vol.48 , pp. 689-723
    • Zhou, S.F.1
  • 17
    • 67649389513 scopus 로고    scopus 로고
    • Neurotoxic thioether adducts of MDMA identified in human urine after Ecstasy ingestion
    • Perfetti X, O'Mathúna B, Pizarro N, Cuyàs E, Khymenets O, et al. (2009) Neurotoxic thioether adducts of MDMA identified in human urine after Ecstasy ingestion. Drug Metabol Disp 37: 1448-1455.
    • (2009) Drug Metabol Disp , vol.37 , pp. 1448-1455
    • Perfetti, X.1    O'Mathúna, B.2    Pizarro, N.3    Cuyàs, E.4    Khymenets, O.5
  • 18
    • 33750368923 scopus 로고    scopus 로고
    • Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA
    • Yang J, Jamei M, Heydari A, Yeo KR, de la Torre R, et al. (2006) Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA. J Psychopharmacol 20: 842-849.
    • (2006) J Psychopharmacol , vol.20 , pp. 842-849
    • Yang, J.1    Jamei, M.2    Heydari, A.3    Yeo, K.R.4    de la Torre, R.5
  • 20
  • 21
  • 22
    • 79953328535 scopus 로고    scopus 로고
    • Sex Differences in 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy)-Induced Cytochrome P450 2D6 Inhibition in Humans
    • Yubero-Lahoz S, Pardo R, Farré M, O'Mahony B, Torrens M, et al. (2011) Sex Differences in 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy)-Induced Cytochrome P450 2D6 Inhibition in Humans. Clin Pharmacokinet 50: 319-329.
    • (2011) Clin Pharmacokinet , vol.50 , pp. 319-329
    • Yubero-Lahoz, S.1    Pardo, R.2    Farré, M.3    O'Mahony, B.4    Torrens, M.5
  • 23
    • 65949093277 scopus 로고    scopus 로고
    • The consequences of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) induced CYP2D6 inhibition in humans
    • O'Mathúna B, Farré M, Rostami-Hodjegan A, Yang J, Cuyàs E, et al. (2008) The consequences of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) induced CYP2D6 inhibition in humans. J Clin Psychopharmacol 28: 523-529.
    • (2008) J Clin Psychopharmacol , vol.28 , pp. 523-529
    • O'Mathúna, B.1    Farré, M.2    Rostami-Hodjegan, A.3    Yang, J.4    Cuyàs, E.5
  • 24
    • 3042744925 scopus 로고    scopus 로고
    • Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV
    • Torrens M, Serrano D, Astals M, Pérez-Domínguez G, Martín-Santos R, (2004) Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. Am J Psychiatry 161: 1231-1237.
    • (2004) Am J Psychiatry , vol.161 , pp. 1231-1237
    • Torrens, M.1    Serrano, D.2    Astals, M.3    Pérez-Domínguez, G.4    Martín-Santos, R.5
  • 25
    • 0032968382 scopus 로고    scopus 로고
    • Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans
    • Mas M, Farré M, de la Torre R, Roset PN, Ortuño J, et al. (1999) Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther 290: 136-145.
    • (1999) J Pharmacol Exp Ther , vol.290 , pp. 136-145
    • Mas, M.1    Farré, M.2    de la Torre, R.3    Roset, P.N.4    Ortuño, J.5
  • 26
    • 18344382718 scopus 로고    scopus 로고
    • Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis
    • Pizarro N, Ortuño J, Farré M, Hernández-López C, Pujadas M, et al. (2002) Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis. J Anal Toxicol 26: 157-165.
    • (2002) J Anal Toxicol , vol.26 , pp. 157-165
    • Pizarro, N.1    Ortuño, J.2    Farré, M.3    Hernández-López, C.4    Pujadas, M.5
  • 28
    • 77949632773 scopus 로고    scopus 로고
    • Errors and reproducibility of DNA array-based detection of allelic variants in ADME genes: PHARMAchip
    • Cuyàs E, Olano-Martín E, Khymenets O, Hernández L, Jofre-Monseny L, et al. (2010) Errors and reproducibility of DNA array-based detection of allelic variants in ADME genes: PHARMAchip. Pharmacogenomics 11: 257-266.
    • (2010) Pharmacogenomics , vol.11 , pp. 257-266
    • Cuyàs, E.1    Olano-Martín, E.2    Khymenets, O.3    Hernández, L.4    Jofre-Monseny, L.5
  • 29
    • 0033941158 scopus 로고    scopus 로고
    • Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects
    • Cami J, Farré M, Mas M, Roset PN, Poudevida S, et al. (2000) Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects. J Clin Psychopharmacol 20: 455-466.
    • (2000) J Clin Psychopharmacol , vol.20 , pp. 455-466
    • Cami, J.1    Farré, M.2    Mas, M.3    Roset, P.N.4    Poudevida, S.5
  • 30
    • 36348943019 scopus 로고    scopus 로고
    • Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics
    • Farré M, Abanades S, Roset PN, Peiró AM, Torrens M, et al. (2007) Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics. J Pharmacol Exp Ther 323: 954-962.
    • (2007) J Pharmacol Exp Ther , vol.323 , pp. 954-962
    • Farré, M.1    Abanades, S.2    Roset, P.N.3    Peiró, A.M.4    Torrens, M.5
  • 31
    • 0036339071 scopus 로고    scopus 로고
    • Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans
    • Gaedigk A, Bradford LD, Marcucci KA, Leeder JS, (2002) Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans. Clin Pharmacol Ther 72: 76-89.
    • (2002) Clin Pharmacol Ther , vol.72 , pp. 76-89
    • Gaedigk, A.1    Bradford, L.D.2    Marcucci, K.A.3    Leeder, J.S.4
  • 32
    • 0028264457 scopus 로고
    • Ethnic differences in erythrocyte catechol-O-methyltransferase activity in black and white Americans
    • McLeod HL, Fang L, Luo X, Scott EP, Evans WE, (1994) Ethnic differences in erythrocyte catechol-O-methyltransferase activity in black and white Americans. J Pharmacol Exp Ther 270: 26-29.
    • (1994) J Pharmacol Exp Ther , vol.270 , pp. 26-29
    • McLeod, H.L.1    Fang, L.2    Luo, X.3    Scott, E.P.4    Evans, W.E.5
  • 34
    • 34250686532 scopus 로고    scopus 로고
    • The Current State of Knowledge on Age, Sex, and Their Interactions on Clinical Pharmacology
    • Schwartz JB, (2007) The Current State of Knowledge on Age, Sex, and Their Interactions on Clinical Pharmacology. Clin Pharmacol Ther 1: 87-96.
    • (2007) Clin Pharmacol Ther , vol.1 , pp. 87-96
    • Schwartz, J.B.1
  • 35
    • 58149083155 scopus 로고    scopus 로고
    • Serotonergic Neurotoxic Thioether Metabolites of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): Synthesis, Isolation, and Characterization of Diastereoisomers
    • Pizarro N, de la Torre R, Joglar J, Okumura N, Perfetti X, et al. (2008) Serotonergic Neurotoxic Thioether Metabolites of 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): Synthesis, Isolation, and Characterization of Diastereoisomers. Chem Res Toxicol 21: 2272-2279.
    • (2008) Chem Res Toxicol , vol.21 , pp. 2272-2279
    • Pizarro, N.1    de la Torre, R.2    Joglar, J.3    Okumura, N.4    Perfetti, X.5
  • 39
    • 79960573947 scopus 로고    scopus 로고
    • The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans
    • Hysek CM, Simmler LD, Ineichen M, Grouzmann E, Hoener MC, et al. (2011) The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans. Clin Pharmacol Ther 90: 246-255.
    • (2011) Clin Pharmacol Ther , vol.90 , pp. 246-255
    • Hysek, C.M.1    Simmler, L.D.2    Ineichen, M.3    Grouzmann, E.4    Hoener, M.C.5
  • 40
    • 0035674880 scopus 로고    scopus 로고
    • Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies
    • Liechti ME, Vollenweider FX, (2001) Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies. Hum Psychopharmacol 16: 589-598.
    • (2001) Hum Psychopharmacol , vol.16 , pp. 589-598
    • Liechti, M.E.1    Vollenweider, F.X.2
  • 41
    • 34748813696 scopus 로고    scopus 로고
    • Evolving knowledge of sex differences in brain structure, function, and chemistry
    • Cosgrove KP, Mazure CM, Staley JK, (2007) Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry 62: 847-855.
    • (2007) Biol Psychiatry , vol.62 , pp. 847-855
    • Cosgrove, K.P.1    Mazure, C.M.2    Staley, J.K.3
  • 43
    • 33845746879 scopus 로고    scopus 로고
    • High systolic blood pressure is associated with Val/Val genotype in the catechol-o-methyltransferase gene The Nord-Trøndelag Health Study (HUNT)
    • Hagen K, Pettersen E, Stovner LJ, Skorpen F, Holmen J, et al. (2007) High systolic blood pressure is associated with Val/Val genotype in the catechol-o-methyltransferase gene The Nord-Trøndelag Health Study (HUNT). Am J Hypertens 20: 21-26.
    • (2007) Am J Hypertens , vol.20 , pp. 21-26
    • Hagen, K.1    Pettersen, E.2    Stovner, L.J.3    Skorpen, F.4    Holmen, J.5
  • 44
    • 12444344813 scopus 로고    scopus 로고
    • Preliminary evidence of the cardiovascular effects of polysubstance misuse in nightclubs
    • Cole JC, Sumnall HR, Smith GW, Rostami-Hodjegan A, (2005) Preliminary evidence of the cardiovascular effects of polysubstance misuse in nightclubs. J Psychopharmacol. 19: 67-70.
    • (2005) J Psychopharmacol , vol.19 , pp. 67-70
    • Cole, J.C.1    Sumnall, H.R.2    Smith, G.W.3    Rostami-Hodjegan, A.4
  • 45
    • 80052329709 scopus 로고    scopus 로고
    • MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study
    • Parrott AC, Gibbs A, Scholey AB, King R, Owens K, et al. (2011) MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study. Psychopharmacology (Berl) 215: 527-536.
    • (2011) Psychopharmacology (Berl) , vol.215 , pp. 527-536
    • Parrott, A.C.1    Gibbs, A.2    Scholey, A.B.3    King, R.4    Owens, K.5
  • 49
    • 58149474177 scopus 로고    scopus 로고
    • Perspective: sex matters: gonadal steroids and the brain
    • Young EA, Becker JB, (2009) Perspective: sex matters: gonadal steroids and the brain. Neuropsychopharmacology 34: 537-538.
    • (2009) Neuropsychopharmacology , vol.34 , pp. 537-538
    • Young, E.A.1    Becker, J.B.2
  • 50
    • 33750084178 scopus 로고    scopus 로고
    • Cortical trapping of alpha-[(11)C]methyl-l-tryptophan, an index of serotonin synthesis, is lower in females than males
    • Sakai Y, Nishikawa M, Leyton M, Benkelfat C, Young SN, et al. (2006) Cortical trapping of alpha-[(11)C]methyl-l-tryptophan, an index of serotonin synthesis, is lower in females than males. Neuroimage 33: 815-824.
    • (2006) Neuroimage , vol.33 , pp. 815-824
    • Sakai, Y.1    Nishikawa, M.2    Leyton, M.3    Benkelfat, C.4    Young, S.N.5
  • 51
    • 0037947438 scopus 로고    scopus 로고
    • Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine
    • Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, et al. (2003) Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 100: 6186-6191.
    • (2003) Proc Natl Acad Sci USA , vol.100 , pp. 6186-6191
    • Mattay, V.S.1    Goldberg, T.E.2    Fera, F.3    Hariri, A.R.4    Tessitore, A.5
  • 52
    • 36049008131 scopus 로고    scopus 로고
    • The role of estradiol and progesterone in modulating the subjective effects of stimulants in humans
    • Evans SM, (2007) The role of estradiol and progesterone in modulating the subjective effects of stimulants in humans. Exp Clin Psychopharmacol 15: 418-426.
    • (2007) Exp Clin Psychopharmacol , vol.15 , pp. 418-426
    • Evans, S.M.1
  • 53
    • 80053302164 scopus 로고    scopus 로고
    • Females are more vulnerable to drug abuse than males: evidence from preclinical studies and the role of ovarian hormones
    • Anker JJ, Carroll ME, (2011) Females are more vulnerable to drug abuse than males: evidence from preclinical studies and the role of ovarian hormones. Curr Top Behav Neurosci 8: 73-96.
    • (2011) Curr Top Behav Neurosci , vol.8 , pp. 73-96
    • Anker, J.J.1    Carroll, M.E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.